Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aimmune Therapeutics, Inc.    AIMT

AIMMUNE THERAPEUTICS, INC.

(AIMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019
Capitalization1 7801 0231 9241 4822 119
Entreprise Value (EV)1 7801 0231 9241 1782 029
P/E ratio -9,81x-10,8x-14,5x-6,52x-8,43x
Yield -----
Capitalization / Revenue -----
EV / Revenue -----
EV / EBITDA -21,7x-12,6x-14,5x-5,51x-8,26x
Price to Book ---4,97x20,5x
Nbr of stocks (in thousands) 42 24950 04550 86461 96863 300
Reference price (USD) 18,520,537,823,933,5
Last update 02/20/201802/28/201902/27/202002/27/202002/27/2020
1
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales ------
EBITDA1 -11,1-35,9-81,0-132-214-246
Operating profit (EBIT)1 -11,1-36,0-81,5-133-215-250
Operating Margin ------
Pre-Tax Profit (EBT)1 -11,1-35,8-80,8-131-211-248
Net income1 -11,1-35,8-80,8-131-211-248
Net margin ------
EPS2 -3,80-1,88-1,89-2,61-3,67-3,97
Dividend per Share ------
Last update 03/15/201702/20/201802/28/201902/27/202002/27/202002/27/2020
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt ------
Net Cash position ----30489,6
Leverage (Debt / EBITDA) ----1,42x0,36x
Free Cash Flow1 -5,61-20,2-36,2-60,9-100-120
ROE (Net Profit / Equities) -181%-34,6%-32,8%-56,6%-88,4%-123%
Shareholders' equity1 6,15103246232238201
ROA (Net Profit / Asset) -94,7%-20,9%-19,9%-32,9%-49,3%-57,4%
Assets1 11,7171405399428433
Book Value Per Share ----4,811,63
Cash Flow per Share ----1,731,25
Capex1 0,061,717,676,439,428,05
Capex / Sales ------
Last update 03/15/201702/20/201802/28/201902/27/202002/27/202002/27/2020
1 USD in Million
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
2 268 296 794
Number of employees
339
Free-Float
77,8%
Free-Float capitalization (USD)
1 765 108 594
EPS & Dividend